Mar 3, 2020
PRINCETON, N.J., March 4, 2020 /PRNewswire/ -- NovoPath, Inc. announces that its client Rahway Pathology, P.A., utilizing NovoPathTM software, was the first practice in the U.S. to upload 2019 Merit-based Incentive Payment System (MIPS) data to the College of American Pathologists (CAP) Pathologists Quality Registry. The CAP's registry will transmit this data to the Centers of Medicare and Medicaid Services (CMS) once the CMS submission portal is open this year.
NovoPath's quality metrics and data export capabilities give users a hassle-free way of automatically collecting and reporting quality data to meet all CMS requirements in a timely manner.
"NovoPath captures reportable MIPS data for Quality Measures and automates the process of tracking cases eligible for MIPS reporting," said Hina Kharbey, Vice President of Business Strategy for NovoPath. "In addition, NovoPath clients can interface with a registry of their choice for reporting. We're very pleased to help Rahway Pathology track, collect, and upload the data to the Pathologists Quality Registry."
"We are committed to meeting CMS MIPS requirements as this will allow us to continue to provide the high level of quality and service our clients and patients expect," said Dr. Michael Gistrak, Co-Chairman at Rahway Pathology.
"The CAP congratulates Rahway Pathology on being the first practice to successfully upload all its 2019 quality performance category data and finish its data entry with the Pathologists Quality Registry," said CAP President-elect Emily E. Volk, MD, MBA, FCAP, who chairs the Pathologists Quality Registry ad hoc committee. "The partnership between the CAP's Pathologists Quality Registry, NovoPath, and Rahway Pathology is one that can be emulated by other practices to ensure their pathologists have the best qualified clinical data registry for continuous quality improvement and demonstrating their value in MIPS."
To experience the benefits of NovoPath firsthand, visit www.NovoPath.com and request a complimentary demonstration.
About NovoPath
NovoPath is an ISO 9001certified U.S.-based Lab Information Systems (LIS) company that serves the Anatomic and Clinical Pathology, Molecular and Genetic Testing, and Clinical Trials markets. We partner with your lab to identify efficiencies, improve workflow and reduce the probability of human error so you can focus on excellent patient care. Built on more than 25 years of industry partnerships, our flexible and reliable workflow and business solutions are engineered to empower your lab to perform at its best. Our clients include national and regional reference labs, university and teaching hospitals, regional and community hospitals, and specialty labs.
Media Contact:
Wally Soufi
732-329-3209
[email protected]
SOURCE NovoPath, Inc.
Related Links
People are increasingly falling behind on credit card repayments, so here's the best way to get debt advice.
The journey of one banana from farm to store shows how the war’s economic effects have cascaded into some surprising industries.
The Institute for Fiscal Studies says the government will need a "top-up" of billions of pounds if it wants to meet its spending plans.
The education minister has warned it would immediately cost his department £20m a year at a time when it is already struggling to balance its budget.
Brad Smith calls for global rules on AI, and says the UK is in the "best position" to lead the charge.
The rural communities vulnerable to heating oil prices rises as the weather gets colder.
Backdated paperwork also made the Russian oligarch’s yachts and mansions disappear from accounts, investigation finds.
After four days touring the frontlines of China's economic evolution, from Xinyu, an age-old manufacturing hub reinventing itself with advanced industries, to the bustling entrepreneurial engine of Wenzhou, the cradle of the country's private sector, a group of former international political leaders and scholars converged in Beijing on Sunday for the Mingde Strategic Dialogue 2026.
One in 10 scams reported to Citizens Advice relate to fraudsters charging for work not done, or done badly.
Both Republican and Democratic lawmakers have criticised the deal, which was announced weeks before the US midterm elections.
The French firm is reinventing the classic model as carmakers come under pressure from Chinese rivals.
It is the third time this week that Ukraine has targeted Russian tech giant Yandex, forcing the company to suspend its operations.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.